1. Four bedaquiline-pretomanid-linezolid treatment groups had a favorable outcome for the treatment of drug-resistant tuberculosis. 2. The treatment group with ...
1. For children with non-severe tuberculosis, 4 months of antituberculosis treatments was non-inferior to 6 months of antituberculosis treatments. 2. ...
1. For children with non-severe tuberculosis, 4 months of antituberculosis treatments was non-inferior to 6 months of antituberculosis treatments. 2. ...
1. Rifapentine-moxifloxacin treatment was shown to be non-inferior compared to standard therapy for tuberculosis. 2. Rifapentine without moxifloxacin treatment was ...
1. Rifapentine-moxifloxacin treatment was shown to be non-inferior compared to standard therapy for tuberculosis. 2. Rifapentine without moxifloxacin treatment was ...
1. After 3 years of weekly vitamin D supplementation, the proportion of children who tested positive on interferon-gamma release assays ...
1. When compared to 9 months of isoniazid, 4 months of rifampin was a non-inferior alternative treatment of latent tuberculosis ...
1. After 3 years of weekly vitamin D supplementation, the proportion of children who tested positive on interferon-gamma release assays ...
1. Expression of IFN-α is found to be lower after successful treatment of tuberculosis. Evidence Rating Level: 2 (Good) Tuberculosis ...
1. When compared to 9 months of isoniazid, 4 months of rifampin was a non-inferior alternative treatment of latent tuberculosis ...
